Ritonavir & Lopinavir Suppliers & Bulk Manufacturers
Available Forms: Tablet and Oral Solution
Available Strengths: Tab: Lopinavir 200 mg + Ritonavir 50 mg; oral solution:80 mg / 20 mg per mL
Reference Brands: Kaletra(US & EU)
Category: Anti Viral
Ritonavir & Lopinavir is available in Tablet and Oral Solution and strengths such as Tab: Lopinavir 200 mg + Ritonavir 50 mg; oral solution:80 mg / 20 mg per mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Ritonavir & Lopinavir is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Ritonavir & Lopinavir can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: Lopinavir & Ritonavir Tablets, widely marketed as Kaletra®, are a fixed-dose combination of two protease inhibitors used in the treatment of HIV-1 infection. Each tablet typically contains Lopinavir 200 mg and Ritonavir 50 mg, with Ritonavir boosting the effectiveness of Lopinavir. This antiretroviral combination remains vital in HIV care, especially in resource-limited settings and global treatment programs. PharmaB2B platforms connect global buyers, NGOs, and procurement agencies with WHO-GMP and USFDA-approved manufacturers offering bulk supply at competitive rates. Ideal for tenders and institutional supply, this therapy supports consistent, affordable access to HIV medications worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Tafenoquine
Strength:
100mg, 150mg
Form: Tablets
Reference Brands: Arakoda (USA), Krintafel(USA)
View DetailsTipranavir
Strength:
250 mg, 100 mg/mL
Form: Capsules / Oral Solution
Reference Brands: Aptivus (USA/EU)
View DetailsAbacavir+Lamivudine
Strength:
600mg+300mg
Form: Tablets / Oral solution
Reference Brands: Epzicom (USA), Kivexa(USA/EU), Ziagen (USA/EU)
View DetailsQuick Response Guaranteed | Verified Suppliers